Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 55 min ago
Peer-reviewedLicence not statedRSC Medicinal Chemistry

Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia

  • Lorenza Destro
  • Valentina Crippa
  • Daniela Gabbia
  • Marco Roverso
  • Sara Bogialli
  • Paolo Zardi
  • Giovanni Marzaro
  • Luca Mologni
  • Alfonso Zambon
Open at sourcePDFDOICite

Related

  1. Machine-learning-guided discovery of selective CK2 inhibitors with reduced CDK off-target activity
    Huiyan Ying, Weikaixin Kong, Aron Schulman +9
    Communications ChemistryPeer-reviewedCC BY 4.0General chemistryNatureCrossref
  2. Metabolically Controlled Oncological Treatment: An Evidence-Graded Framework Integrating Metabolic Reprogramming, Targeted Drug Delivery, and Standard Oncological Care
    Mehmet Salih Iyikesici, Oral Oncul, Sena Sen +3
    MoleculesPeer-reviewedCC BY 4.0General chemistryCrossref
  3. Ligand-Based Design of Lyn-Selective Type II Kinase Inhibitors by Rational Tail Modification of Imatinib
    Avi L. Benitah, Hadi H. Choudhary, Khalid Hanafy +2
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
  4. Surface-Aware Generative Design of Selective Inhibitors for Protein–Membrane Adsorption
    ByungUk Park, Reid C. Van Lehn
    ChemRxivPreprintCC BY-NCFull textGeneral chemistryChemRxiv
  5. Discovery of Nanomolar CDK2 Inhibitors Using Boltz-2
    Sven M. Papidocha, Yoshihiro Ogura, Jiahe Ren +4
    ChemRxivPreprintCC BYFull textGeneral chemistryChemRxiv

Cite

BibTeXRIS
BibTeX
@article{destro2026discovery,
  title = {{Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia}},
  author = {Lorenza Destro and Valentina Crippa and Daniela Gabbia and Marco Roverso and Sara Bogialli and Paolo Zardi and Giovanni Marzaro and Luca Mologni and Alfonso Zambon},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  month = oct,
  doi = {10.1039/d4md00956h},
  url = {https://hal.science/hal-05790950v1},
}
RIS
TY  - JOUR
TI  - Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia
AU  - Lorenza Destro
AU  - Valentina Crippa
AU  - Daniela Gabbia
AU  - Marco Roverso
AU  - Sara Bogialli
AU  - Paolo Zardi
AU  - Giovanni Marzaro
AU  - Luca Mologni
AU  - Alfonso Zambon
PY  - 2026
DA  - 2026/10/10
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d4md00956h
UR  - https://hal.science/hal-05790950v1
SN  - 2632-8682
ER  -